Jagsonpal Pharmaceuticals Limited
Jagsonpal Pharmaceuticals Ltd is primarily engaged in the manufacturing and trading of pharmaceutical products and APIs. It has operations in India and caters to both domestic and international markets.
What Jagsonpal files
- Others57
- Investor Meet36
- Important36
- Updates18
- Dividend/Bonus9
- Board Meeting7
Jagsonpal Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication
Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 18, 2026
Jagsonpal Pharma is ensuring shareholder access to the 2025-26 Annual Report and 47th AGM notice. Shareholders without registered emails received web-links for these documents. The AGM will be held virtually.
Jagsonpal Pharma allotted 27,950 equity shares to employees via its ESOP 2022. This issuance raised approximately Rs. 0.31 Cr from option exercises, expanding the company's total shares outstanding and enhancing employee participation.
Jagsonpal Pharma delivered robust Q1 FY27 financial results: revenue grew 9% to Rs. 82 Cr, EBITDA rose 21% to Rs. 19 Cr, and PAT increased 22% to Rs. 13 Cr. Gross margins surpassed 65%. A key strategic move was acquiring an 85% stake in Aequitas Healthcare for Rs. 20.8 Cr,...